IMR Press / CEOG / Volume 21 / Issue 2 / pii/1994018

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Case Report

Leiomyomas in patients receiving Tamoxifen

Show Less
1 Department B of Obstetrics & Gynecology Inst. Univ. of Torino, Italy
Clin. Exp. Obstet. Gynecol. 1994, 21(2), 94–98;
Published: 10 June 1994
Abstract

In literature there have been only 8 cases of unavoidable laparotomy due to uterine leiomyomas performed in patients with breast cancer on Tamoxifen (TAM). Our article describes two cases of rapidly growing leiomyomas in patients treated with TAM: one of these underwent abdominal hysterectomy while the second stopped taking TAM and began therapy with Triptorelin. This therapeutical alternative could be a useful choice.

Keywords
Leiomyoma
Tamoxifen
Breast neoplasms
Share
Back to top